The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Open accessAbstract
A growing body of evidence implicates ceramide and/or its glycosphingolipid metabolites in the pathogenesis of insulin resistance. We have developed a highly specific small molecule inhibitor of glucosylceramide synthase, an enzyme that catalyzes a necessary step in the conversion of ceramide to glycosphingolipids. In cultured 3T3-L1 adipocytes, the iminosugar derivative N-(5′-adamantane-1′-yl-methoxy)-pentyl-1-deoxynojirimycin (AMP-DNM) counteracted tumor necrosis factor-α–induced abnormalities in glycosphingolipid concentrations and concomitantly reversed abnormalities in insulin signal transduction. When administered to mice and rats, AMP-DNM significantly reduced glycosphingolipid but not ceramide concentrations in various tissues. Treatment of ob/ob mice with AMP-DNM normalized their elevated tissue glucosylceramide levels, markedly lowered circulating glucose levels, improved oral glucose tolerance, reduced A1C, and improved insulin sensitivity in muscle and liver. Similarly beneficial metabolic effects were seen in high fat–fed mice and ZDF rats. These findings provide further evidence that glycosphingolipid metabolites of ceramide may be involved in mediating the link between obesity and insulin resistance and that interference with glycosphingolipid biosynthesis might present a novel approach to the therapy of states of impaired insulin action such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Self-citationUnger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Miglitol: A Review of its Therapeutic Potential in Type 2 Diabetes Mellitus
Scott, L. J., & Spencer, C. M. (2000) · Drugs · doi:10.2165/00003495-200059030-00012 · Cited by 451
Regulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355
Intracellular signal transduction pathways activated by ceramide and its metabolites
Ruvolo, P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 355
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
TNF-α and insulin resistance: Summary and future prospects
Peraldi, P., & Spiegelman, B. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865715292 · Cited by 286
Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2005) · Hypertension · doi:10.1161/01.hyp.0000163475.04421.e4 · Cited by 286
POWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267
The role of intramuscular lipid in insulin resistance
Hegarty, B. D., Furler, S. M., Ye, J., Cooney, G. J., & Kraegen, E. W. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01162.x · Cited by 256
Mutation of β-glucosidase 2 causes glycolipid storage disease and impaired male fertility
Yildiz, Y., Matern, H., Thompson, B., Allegood, J. C., Warren, R. L., Ramirez, D. M. O., Hammer, R. E., Hamra, F. K., Matern, S., & Russell, D. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29224 · Cited by 222
Generation of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase
Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186
Self-citationIdentification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2
Boot, R. G., Verhoek, M., Donker-Koopman, W., Strijland, A., van Marle, J., Overkleeft, H. S., Wennekes, T., & Aerts, J. M. F. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610544200 · Cited by 185
Self-citationNeville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Lubricating cell signaling pathways with gangliosides
Allende, M. L., & Proia, R. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00376-7 · Cited by 156
Kabayama, K. (2004) · Glycobiology · doi:10.1093/glycob/cwh135 · Cited by 155
Nojima, H., Kimura, I., Chen, F.-J., Sugihara, Y., Haruno, M., Kato, A., & Asano, N. (1998) · Journal of Natural Products · doi:10.1021/np970277l · Cited by 149
Andersson, U., Butters, T., Dwek, R., & Platt, F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00384-6 · Cited by 141
Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells.
Ebina, Y., Edery, M., Ellis, L., Standring, D. N., Beaudoin, J. D., Roth, R. A., & Rutter, W. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8014 · Cited by 129
Grefhorst, A., van Dijk, T. H., Hammer, A., van der Sluijs, F. H., Havinga, R., Havekes, L. M., Romijn, J. A., Groot, P. H. E., Reijngoud, D., & Kuipers, F. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2005 · Cited by 126
Self-citationNugent, C., Prins, J. B., Whitehead, J. P., Savage, D. B., Wentworth, J. M., Chatterjee, K., & O’Rahilly, S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0715 · Cited by 94
Self-citationBiochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.
Aerts, J., Hollak, C., Boot, R., & Groener, A. (2003) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.2003.1273 · Cited by 84
Self-citationGanglioside GM3 inhibition of EGF receptor mediated signal transduction
Rebbaa, A., Hurh, J., Yamamoto, H., Kersey, D. S., & Bremer, E. G. (1996) · Glycobiology · doi:10.1093/glycob/6.4.399 · Cited by 83
van Weely, S., Leeuwen, M. B. V., Jansen, I. D. C., Bruijn, M. A. C. D., Brouwer-Kelder, E. M., Schram, A. W., Sá-Miranda, C., Barranger, J. A., Petersen, E. M., Goldblatt, J., et al. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90066-i · Cited by 53
Self-citationShayman, J. A., Abe, A., & Hiraoka, M. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000016739.32089.55 · Cited by 28
TNF-α and insulin resistance: Summary and future prospects
Peraldi, P., & Spiegelman, B. M. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5647-3_18 · Cited by 22
Inhibitory effect of ceramide on insulin-induced protein kinase Cζ translocation in rat adipocytes
Miura, A., Kajita, K., Ishizawa, M., Kanoh, Y., Kawai, Y., Natsume, Y., Sakuma, H., Yamamoto, Y., Yasuda, K., & Ishizuka, T. (2003) · Metabolism · doi:10.1053/meta.2003.50011 · Cited by 18
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Cawthorn, W. P., & Sethi, J. K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 791
Self-citationHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
Metadata
- Authors
- Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., Sethi, J. K., O'Rahilly, S., & Overkleeft, H. S.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-05-01
- Volume
- 56
- Issue
- 5
- Pages
- 1341-1349
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2148391445
- Cited by
- 301
- References
- 33
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.